Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Stock Price, Quote & AI Analysis

Live RYTM stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Rhythm Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Rhythm Pharmaceuticals, Inc. Common Stock (RYTM), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$6,851,790,869.52
52W Range
$45.91 - $122.20
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 24, 2026 Q4
After Hours
EPS Estimate: $-0.8271
Revenue Estimate: $57,092,970.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Rhythm Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Rhythm Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Company Details
Market Cap
$7.27B
Shares Outstanding
66,736,100
Weighted Shares Outstanding
66,736,056
CEO
David P. Meeker
Address
222 BERKELEY STREET, BOSTON, MA, 02116
Employees
283
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Rhythm Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...